Create
Log in
Sign up
Golden has been acquired by ComplyAdvantage.
Read about it here ⟶
US Patent 10633379 Bromodomain inhibitors
Overview
Structured Data
Issues
Contributors
Activity
All edits
Edits on 21 May, 2023
"Remove website redirecting to Patent Public Search front page"
Golden AI
edited on 21 May, 2023
Edits made to:
Infobox
(
-1
properties)
Infobox
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=10633379
0
0
Edits on 27 Mar, 2023
"update citations for inverse infoboxes"
Golden AI
edited on 27 Mar, 2023
Infobox
Patent Citations
US Patent 10085985 Bromodomain inhibitors
0
Edits on 25 Mar, 2023
"Entity importer update"
Golden AI
edited on 25 Mar, 2023
Infobox
Is a
Patent
0
Patent Applicant
AbbVie Inc.
0
Current Assignee
AbbVie Inc.
0
Patent Jurisdiction
United States Patent and Trademark Office
0
Patent Number
10633379
0
Date of Patent
April 28, 2020
0
Patent Application Number
16093483
0
Date Filed
April 14, 2017
0
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=10633379
0
Patent Citations
US Patent 10035800 Substituted 1,4,10-triazadibenzo[cd,f]azulenes, substituted 1,4,5,10-tetraazadibenzo[cd,f]azulenes and substituted 1,4,5,7,10-pentaazadibenzo[cd,f]azulenes as bromodomain inhibitors
0
US Patent 10085985 Bromodomain inhibitors
0
US Patent 10131657 Bromodomain inhibitors
0
Patent Citations Received
US Patent 11584756 Heterocyclic compounds as BET inhibitors
0
Patent Primary Examiner
Nizal S Chandrakumar
0
Edits on 23 Feb, 2023
"update inverses"
Golden AI
edited on 23 Feb, 2023
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent Citations Received
US Patent 11584756 Heterocyclic compounds as BET inhibitors
0
Edits on 26 Sep, 2022
"Entity importer update"
Golden AI
edited on 26 Sep, 2022
Infobox
Is a
Patent
0
Patent Applicant
AbbVie Inc.
0
Current Assignee
AbbVie Inc.
0
Patent Jurisdiction
United States Patent and Trademark Office
0
Patent Number
10633379
0
Date of Patent
April 28, 2020
0
Patent Application Number
16093483
0
Date Filed
April 14, 2017
0
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=10633379
0
Patent Citations
US Patent 10035800 Substituted 1,4,10-triazadibenzo[cd,f]azulenes, substituted 1,4,5,10-tetraazadibenzo[cd,f]azulenes and substituted 1,4,5,7,10-pentaazadibenzo[cd,f]azulenes as bromodomain inhibitors
0
US Patent 10085985 Bromodomain inhibitors
0
US Patent 10131657 Bromodomain inhibitors
0
Patent Primary Examiner
Nizal S Chandrakumar
0
Edits on 22 Sep, 2022
"update citations for inverse infoboxes"
Golden AI
edited on 22 Sep, 2022
Infobox
Patent Citations
US Patent 10085985 Bromodomain inhibitors
0
Edits on 8 Jun, 2022
"Entity importer update"
Golden AI
edited on 8 Jun, 2022
Edits made to:
Infobox
(
+1
properties)
Infobox
Website URL
https://pdfpiw.uspto.gov/.piw?Docid=10633379
Edits on 2 Feb, 2022
"Created via: Entity Importer"
Golden AI
created this topic on 2 Feb, 2022
Edits made to:
Infobox
(
+12
properties)
US Patent 10633379 Bromodomain inhibitors
Infobox
Is a
Patent
Patent applicant
AbbVie Inc.
Current assignee
AbbVie Inc.
Patent jurisdiction
United States Patent and Trademark Office
Patent number
10633379
Date of patent
April 28, 2020
Patent application number
16093483
Date Filed
April 14, 2017
Patent citations
US Patent 10035800 Substituted 1,4,10-triazadibenzo[cd,f]azulenes, substituted 1,4,5,10-tetraazadibenzo[cd,f]azulenes and substituted 1,4,5,7,10-pentaazadibenzo[cd,f]azulenes as bromodomain inhibitors
US Patent 10085985 Bromodomain inhibitors
US Patent 10131657 Bromodomain inhibitors
Patent primary examiner
Nizal S Chandrakumar
Find more entities like US Patent 10633379 Bromodomain inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Company
Home
Press & Media
Blog
Careers
WE'RE HIRING
Products
Knowledge Graph
Query Tool
Data Requests
Knowledge Storage
API
Pricing
Enterprise
ChatGPT Plugin
Legal
Terms of Service
Enterprise Terms of Service
Privacy Policy
Help
Help center
API Documentation
Contact Us
SUBSCRIBE